Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F9LX4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,987
Award facts
- Contract value 100% obligated
- $11,986.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,986.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a prescription pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, and was not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and subsidiary of Cencora, Inc., serving as a critical vendor for federal medical procurement across military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, and specialized medical supplies. The parent company, Cencora, Inc., also maintains a separate IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, demonstrating the significant role both entities play in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9LX4?
SPE2DR26F9LX4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LX4 worth?
The government has obligated $11,987 on SPE2DR26F9LX4.
Is contract SPE2DR26F9LX4 an order under another contract?
Yes. SPE2DR26F9LX4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LX4 competed?
The extent of competition for SPE2DR26F9LX4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award